News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MWG Biotech AG "Partner of Choice" Of Pfizer Inc. (PFE)



10/19/2005 5:10:35 PM

EBERSBERG, Germany--(BUSINESS WIRE)--March 24, 2004--MWG Biotech AG (FWB:NWU), Germany, announces the conclusion of a worldwide framework agreement with Pfizer Inc., New York, NY, USA. In the framework of this agreement MWG Biotech AG is "Partner of Choice" for supplying the products and services of the MWG Biotech business units Genomic Information (sequencing), Genomic Synthesis (oligonucleotides, synthetic nucleic acids), and Genomic Diagnosis (microarrays) to Pfizer Inc. Financial and other details were not disclosed.

http://www.THE-MWG.com

Contact:

MWG Biotech AG, Ebersberg Ulrike Schramm Public Relations Tel. +49-8092-8289-929 Email: uschramm@mwgdna.com

Source: MWG Biotech AG


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES